Parkin substrates accumulate in pathological situations where parkin is inactivated, such as in patients with parkin mutations, sporadic PD, parkin knockout mice, and following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication in mice12,13,26. Here, PRKN is linked to Parkinson disease.